Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;39(8):897-903.
doi: 10.1055/s-0040-1719182. Epub 2020 Nov 17.

Rooming-in for Infants at Risk for Neonatal Abstinence Syndrome: Outcomes 5 Years following Its Introduction as the Standard of Care at One Hospital

Affiliations

Rooming-in for Infants at Risk for Neonatal Abstinence Syndrome: Outcomes 5 Years following Its Introduction as the Standard of Care at One Hospital

Adam Isaiah Newman et al. Am J Perinatol. 2022 Jun.

Abstract

Objective: The practice of rooming-in for opioid-dependent infants was introduced as the standard of care at our hospital following a pilot study which demonstrated that such infants had shorter lengths of stay and were less likely to require pharmacological treatment. We sought to determine whether these benefits have continued, and whether outcomes support continuing to use rooming-in as standard care.

Study design: Opioid-dependent infants delivered at 36 weeks gestation or later between January 1, 2015, and December 31, 2019, were eligible for rooming-in. Charts were reviewed and data were extracted regarding maternal and infant conditions, whether neonatal pharmacological treatment was required, and total length of hospital stay. Outcomes were compared with two historical groups reported in a previous pilot study: 24 healthy near-term opioid-dependent newborns who were admitted directly to the neonatal intensive care unit (NICU) prior to the introduction of rooming-in (May 1, 2012-May 31, 2013), and 20 similar opioid-dependent infants who were the first to room-in at our hospital (September 1, 2013-September 30, 2014).

Results: Only 3.5% of 57 infants who roomed-in during the 5-year study period required pharmacological treatment, compared with 15% who roomed-in during the first year of the program's introduction and 83.3% who had been admitted directly to the NICU. The median length of stay remained 5 days for infants rooming-in, compared with 24 days for opioid-dependent infants in the cohort admitted to the NICU.

Conclusion: Early observations of the benefits of rooming-in on neonatal outcomes were sustained. Infants allowed to room-in were significantly less likely to require initiation of pharmacotherapy and a prolonged hospital stay than similar infants prior to the implementation of rooming-in as standard care. A large proportion of the infants who might have benefited from rooming-in required admission to the NICU for reasons other than neonatal abstinence syndrome (NAS).

Key points: · Benefits of rooming-in for near-term opioid-dependent infants were sustained or increased.. · Rooming-in is sustainable as standard care for these newborns.. · Many infants required admission to NICU for reasons other than NAS..

PubMed Disclaimer

Conflict of interest statement

A.I.N. reports personal fees from Knight Therapeutics, outside the submitted work. All the other authors report no conflict of interest.

Similar articles

Cited by

References

    1. Special Advisory Committee on the Epidemic of Opioid Overdoses Opioid-related Harms in Canada Ottawa: Public Health Agency of Canada; March 2020. Accessed August 1, 2020 at:https://health-infobase.canada.ca/substance-related-harms/opioids
    1. Orpana H M, Lang J J, Baxi M. Tendances canadiennes en matière de mortalité liée aux opioïdes et d'invalidité découlant d'un trouble de consommation d'opioïdes, à la lumière de l'Étude sur la charge mondiale de morbidité (1990–2014) Health Promot Chronic Dis Prev Can. 2018;38(06):234–243. - PMC - PubMed
    1. Dawson E, Lew J, Mauer-Vakil D, Van Dijk A, Belanger P, Moore K M. A longitudinal analysis of temporal and spatial incidence of neonatal abstinence syndrome in Ontario: 2003-2016. J Opioid Manag. 2019;15(03):205–212. - PubMed
    1. MacMillan K DL. Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes. Clin Perinatol. 2019;46(04):817–832. - PubMed
    1. Stanford Children's Health Neonatal Abstinence SyndromeMay 2020. Available at: https://www.stanfordchildrens.org/en/topic/default?id=neonatal-abstinenc...https://www.stanfordchildrens.org/en/topic/default?id=neonatal-abstinenc.... Accessed August 1, 2020

Substances